Clinical Trial Update: Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial - Star AF II Study [NA]

View source ↗

Summary

The Substrate and Trigger Ablation for Reduction of Atrial Fibrillation (Star AF II) trial by Abbott Medical Devices has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Star AF II Substrate and Trigger Ablation System

Snippet

Sponsor: Abbott Medical Devices | Conditions: Atrial Fibrillation | NA | Status: COMPLETED